Medically reviewed by Dr Abdul Shafiz Shaikh, BUMS, Reg. No. I-2416.
CBD in India is a nuanced subject. The legal position can depend on the plant part used, the composition of the preparation, its intended purpose, the applicable central and state rules, and whether manufacture, sale and dispensing occur under the required licences. A product should not be treated as lawful merely because its label contains the words “CBD,” “hemp,” “cannabis” or “Ayurvedic.”
For consumers, the safest approach is to verify the exact formulation, manufacturer, licence, label, prescription requirements and professional guidance before ordering or using a cannabinoid- or Vijaya-containing product.
What is CBD?
Cannabidiol, commonly called CBD, is one of the naturally occurring compounds found in plants of the Cannabis genus. CBD is distinct from delta-9-tetrahydrocannabinol, or THC, although full-spectrum extracts can contain multiple naturally occurring plant compounds.
The effects and risks of a finished product cannot be inferred from the term “CBD” alone. Concentration, accompanying cannabinoids, extraction method, route of administration, dosage and other ingredients all matter.
Why the legal position in India requires precision
The Narcotic Drugs and Psychotropic Substances Act, 1985 defines cannabis in specific terms. Its definition includes charas, which covers separated resin, and ganja, meaning flowering or fruiting tops. Seeds and leaves are excluded from the definition of ganja when they are not accompanied by the tops. The Act also regulates certain activities involving narcotic drugs and psychotropic substances while providing for permitted medical and scientific use subject to applicable rules, licences and authorisations.
That distinction does not mean that every leaf-derived or CBD-labelled consumer product is automatically legal throughout India. Manufacturing licences, state excise requirements, drug rules, formulation classification, interstate movement, marketing claims and dispensing conditions can still apply.
Consumers should therefore be cautious of absolute claims such as “all CBD is legal in India” or “no prescription is ever required.”
What should a consumer verify?
Before buying a Vijaya- or cannabinoid-containing formulation, check:
- The legal name and address of the manufacturer.
- The applicable manufacturing and product licence information.
- The complete ingredient list and quantity of each active ingredient.
- The batch number, manufacturing date and expiry date.
- The approved indications and usage instructions on the label.
- Whether a prescription or professional consultation is required.
- Whether the seller has a clear prescription-review and support process.
- Whether safety warnings, contraindications and storage instructions are provided.
- Whether laboratory or quality documents actually apply to the same product and batch.
Why medical review matters
CBD and other cannabinoid-containing products can cause adverse effects and interact with medicines. Public-health sources identify concerns including drowsiness, gastrointestinal effects, changes in alertness, potential liver effects and drug interactions. Risk can vary with dose, formulation, other medicines and the person’s health.
A qualified medical practitioner should review suitability, particularly when a person:
- Takes prescription medicines.
- Has liver disease or abnormal liver tests.
- Is pregnant, planning pregnancy or breastfeeding.
- Is under 18 or elderly.
- Has a history of substance-use problems.
- Has a psychiatric, neurological or serious chronic condition.
- Uses alcohol, sedatives or other substances that can cause drowsiness.
- Needs to drive or operate machinery.
How prescription-gated access should work
A responsible prescription process is more than an upload button. It should include identity and prescription checks, assessment by an appropriately qualified professional, confirmation that the prescribed product and directions match the order, and the ability to approve, request clarification or decline the transaction.
Customers without a valid prescription should be directed to an appropriate consultation pathway rather than encouraged to self-diagnose.
Is CBD proven for every condition advertised online?
No. Research differs significantly by compound, formulation, dose and health condition. Evidence for one prescription cannabinoid product or one medical indication should not be applied to every commercial oil or gummy.
Systematic reviews have reported promising findings in selected settings, but they also emphasize small studies, inconsistent formulations and the need for better evidence. Marketing should reflect these uncertainties and should not convert preliminary research into a guaranteed treatment promise.
Sanan Organix and licensed manufacturing
Sanan Organix is a retail brand operated by Surya Sharma Solutions Private Limited. Its stated manufacturing partner is Mehta Ayurvedic Sansthan. The website should identify which products and activities are covered by the displayed licences and should provide prescription review where applicable.
The manufacturing partner’s licence should not be described as a manufacturing licence held directly by Sanan Organix unless documentation establishes that fact.
Frequently asked questions
Is every CBD product legal in India?
No single answer applies to every product. Plant part, composition, purpose, licence, state requirements and dispensing conditions can affect the legal position.
Can I buy CBD or Vijaya medicine without a prescription?
Requirements depend on the product and applicable rules. If a product requires a prescription, a seller should not dispense it until a valid prescription has been reviewed.
Does “AYUSH approved” mean a product is safe for everyone?
No. A licence or approval does not remove contraindications, adverse effects or drug interactions. Suitability remains individual.
Can CBD interact with medicines?
Yes. Cannabidiol can affect the way some medicines are metabolised, and combined sedative effects may also matter. A qualified practitioner should review current medicines.
References
- India Code, Narcotic Drugs and Psychotropic Substances Act, 1985, Sections 2 and 8: https://www.indiacode.nic.in/
- Central Bureau of Narcotics, Acts, Rules and controlled-substance resources: https://www.cbn.gov.in/
- World Health Organization, Cannabidiol critical review: https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabidiol
- U.S. FDA, cannabis-derived products including CBD—known risks and research gaps: https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis
Medical and legal disclaimer
This article provides general educational information and is not legal or medical advice. Laws, licences and regulatory interpretations can change and may differ by state and product. Consult qualified legal counsel regarding compliance and a qualified medical practitioner regarding personal use.
Explore a related Sanan Organix option
For readers comparing products in this category, review VijayaAmritX Full Spectrum Vijaya Oil. Check the complete label, suitability and precautions, and obtain a qualified consultation or prescription whenever required. This is not a substitute for medical advice.
